Biochemical and molecular characterization of hereditary myeloperoxidase deficiency

Blood

Volumn 90, Issue 10, 1997, Pages 4126-4134

  Romano, Maurizio ^b   Dri, Pietro ^b   Dadalt, Liviana ^b   Patriarca, Pierluigi ^b   Baralle, Francisco E ^a  

^a INTERNATIONAL CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; MYELOPEROXIDASE;

AMINO ACID SUBSTITUTION; ARTICLE; BIOCHEMISTRY; CASE REPORT; CYTOCHEMISTRY; ENZYME DEFICIENCY; GENE DELETION; GENE MUTATION; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; PRESCHOOL CHILD; PRIORITY JOURNAL; SPECTROSCOPY;

EID: 0030732425     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v90.10.4126     Document Type: Article

References (40)

1. Kebanoff SJ: Myeloperoxidase-mediated cytotoxic systems, in Sbarra AJ, Strauss RR (eds): The Reticuloendothelial System, vol 2. New York, Plenum Press, 1980, p 279
2. Bos A, Wever R, Roos D: Characterization and quantification of the peroxidase in human monocytes. Biochim Biophys Acta 525:37, 1978
3. Klebanoff SJ: Oxygen metabolism and the toxic properties of phagocytes. Ann Intern Med 93:480, 1980
4. Klebanoff SJ, Clark RA: The Neutrophils: Functions and Clinical Disorders. North Holland, Amsterdam, Elsevier, 1978
5. 2-halide system: Cytotoxic effect on mammalian tumor cells. Blood 45:161, 1975
6. Klebanoff SJ: Peroxidases in Chemistry and Biology. Boca Raton, FL, CRC Press, 1991
7. Koeffler HP, Ranyard J, Pertcheck M: Myeloperoxidase: Its structure and expression during myeloid differentiation. Blood 65:484, 1985
8. Hasilik A, Pohlmann R, Olsen RL, von FK: Myeloperoxidase is synthesized as larger phosphorylated precursor. EMBO J 3:2671, 1984
9. Nauseef WM: Myeloperoxidase biosynthesis by a human promyelocytic leukemia cell line: Insight into myeloperoxidase deficiency. Blood 67:865, 1986
10. Dri P, Cramer R, Menegazzi R, Patriarca P: Biochemical, functional and clinical aspects of hereditary myeloperoxidase deficiency. Adv Biosci 66:193, 1987
11. Patriarca P, Cramer R, Tedesco F, Kakinuma K: Studies on the mechanism of metabolic stimulation in polymorphonuclear leukocytes during phagocytosis. II. Presence of the NADPH2 oxidizing activity in a myeloperoxidase-deficient subject. Biochim Biophys Ada 385:387, 1975
12. Rosen H, Klebanoff SJ: Chemiluminescence and Superoxide production by myeloperoxidase-deficient leukocytes. J Clin Invest 58:50, 1976
13. Lehrer RI, Cline MJ: Leukocyte myeloperoxidase deficiency and disseminated candidiasis: The role of myeloperoxidase in resistance to Candida infection. J Clin Invest 48:1478, 1969
14. Moosman K, Bojanovsky A: Rezidivierende Candidiosis bei myeloperoxidasemangel. Monatsschr Kinderheilkd 123:408, 1975
15. Cech P, Stalder H, Widmann JJ, Rohner A, Miescher PA: Leukocyte myeloperoxidase deficiency and diabetes mellitus associated with Candida albicans liver abscess. Am J Med 66:149, 1979
16. Parry MF, Root RK, Metcalf JA, Delaney KK, Kaplow LS, Richar WJ: Myeloperoxidase deficiency: Prevalence and clinical significance. Ann Intern Med 95:293, 1981
17. Tobler A, Selsted ME, Miller CW, Johnson KR, Novotny MI, Rovera G, Koeffler HP: Evidence for a pretranslational defect in hereditary and acquired myeloperoxidase deficiency. Blood 73:1980, 1989
18. Selsted ME, Miller CW, Novotny MI, Morris WL, Koeffler HP: Molecular analysis of myeloperoxidase deficiency shows heterogeneous patterns of the complete deficiency state manifested at the genomic, mRNA, and protein level. Blood 82:1317, 1993
19. Kizaki M, Miller CW, Selsted ME, Koeffler HP: Myeloperoxidase (MPO) gene mutation in hereditary MPO deficiency. Blood 83:1935, 1994
20. Nauseef WM, Root RK, Malech HL: Biochemical and immunologic analysis of hereditary myeloperoxidase deficiency. J Clin Invest 71:1297, 1983
21. Nauseef WM, Brigham S, Cogley M: Hereditary myeloperoxidase deficiency due to a missense mutation of arginine 569 to tryptophan. J Biol Chem 269:1212, 1994
22. Nauseef WM, Cogley M, McCormick S: Effect of the R569W missense mutation on the biosynthesis of myeloperoxidase. J Biol Chem 271:9546, 1996
23. Zabucchi G, Menegazzi R, Cramer R, Nardon E, Patriarca P: Mutual influence between eosinophil peroxidase (EPO) and neutrophils: Neutrophils reversibly inhibit EPO enzymatic activity and EPO increases neutrophil adhesiveness. Immunology 69:580, 1990
24. Dri P, Cramer R, Soranzo MR, Comin A, Miotti V, Patriarca P: New approaches to the detection of myeloperoxidase deficiency. Blood 60:323, 1982
25. Kaplow LS: Simplified myeloperoxidase stain using benzidine dihydrochloride. Blood 26:215, 1965
26. Cramer R, Soranzo MR, Dri P, Menegazzi R, Pilotti A, Zabucchi G, Patriarca P: A simple and reliable assay for myeloperoxidase activity in mixed neutrophil-eosinophil cell suspensions: Application to detection of myeloperoxidase deficiency. J Immunol Methods 70:119, 1984
27. Cramer R, Bisiacchi B, de Nicola G, Patriarca P: A comparative study of the biochemical properties of myeloperoxidase and eosinophil peroxidase. Adv Exp Med Biol 121:91, 1979
28. Romano M, Melo C, Baralle FE, Dri P: cDNA clones of myeloperoxidase (MPO) and eosinophil peroxidase (EPO) from human mononuclear cells differentiated into granulocyte precursors in liquid cultures. J Immunol Methods 154:265, 1992
29. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156, 1987
30. Van-Pedersen K, Kornblihtt A, Baralle FE: Expression of human a-globin/fibronectin gene hybrid generates two mRNAs by alternative splicing. EMBO J 3:2511, 1984
31. Odajima T, Yamazaki I: Myeloperoxidase of the leukocyte of normal blood. IV. Some physiochemical properties. Biochim Biophys Acta 284:360, 1972
32. Higgs DR, Goodbourn SEY, Lamb J, Clegg JB, Weatherall DJ: α-Thalassaemia caused by a polyadenylation signal mutation. Nature 306:398, 1983
33. Gourdin MF, Vasconcelos AW, Tabilio A, Divine M, Farcet JP, Reyes F: Human mononuclear phagocyte differentiation: A study of the U-937 cell line by ultrastructural cytochemistry and surface antigen analysis. Br J Haematol 61:281, 1985
34. Zeng J, Fenna RE: X-ray crystal structure of canine myeloperoxidase at 3 Å resolution. J Mol Biol 226:185, 1992
35. Nauseef W, McCormick S, Yi H: Roles of heme insertion and the mannose-6-phosphate receptor in processing of the human myeloid lysosomal enzyme, myeloperoxidase. Blood 80:2622, 1992
36. Kimura S, Ikeda-Saito M: Human myeloperoxidase and thyroid peroxidase, two enzymes with separate and distinct physiological functions, are evolutionarily related members of the same gene family. Proteins 3:113, 1988
37. Kornblihtt AR, Pesce CG, Alonso CR, Cramer P, Sbrebrow A, Werbajh S, Muro A: The fibronectin gene as model for splicing and transcription studies. FASEB J 10:248, 1996
38. Lawrence HJ, Sauvageau G, Ahmadi N, Lopez AR, LeBeau MM, Link M, Humphries K, Largman C: Stage- and lineage-specific expression of the HOXA10 homeobox gene in normal and leukemic hematopoietic cells. Exp Hematol 23:1160, 1995
39. Shapiro MB, Senapathy P: RNA splice junctions of different classes of eukaryotes: Sequence statistics and functional implications in gene expression. Nucleic Acid Res 15:7155, 1987
40. Aoufouchi S, Yélamos J, Milstein C: Nonsense mutations inhibit RNA splicing in a cell-free system: Recognition of mutant codon is independent of protein synthesis. Cell 85:415, 1996